Company Search:
Advanced Search
Sponsored Links
Intra-Cellular Therapies Inc Company Snapshot
Intra-Cellular Therapies Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Intra-Cellular Therapies Inc with three other companies in this sector in the United States: Spero Therapeutics Inc (2016 sales of $335,000.00 ), Revance Therapeutics Inc ($300,000.00 of which 100% was Botulinum Toxin Products), and Dicerna Pharmaceuticals Inc ($295,000.00 of which 100% was RNA Interference (RNAi) Therapeutics).

Sales Analysis. Sales increased substantially in 2016: During the year ended December of 2016, sales at Intra-Cellular Therapies Inc were $330,702.00 . This is an increase of 262.0% versus 2015, when the company's sales were $91,364.00 . Despite this increase, sales are still well below the level achieved in 2014, when Intra-Cellular Therapies Inc reported sales of $577,301.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Intra-Cellular Therapies Inc
  Stock Performance Chart for Intra-Cellular Therapies Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 18.04
(Figures in U.S. Dollars)
1 Week -4.4%   13 Weeks 15.0%  
4 Weeks 12.2%   52 Weeks 32.8%  
Intra-Cellular Therapies Inc Key Data:
  Ticker: ITCI Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 330,702
(Year Ending Jan 2017).
Employees: 41
  Currency: U.S. Dollars Market Cap: 984,580,373
  Fiscal Yr Ends: December Shares Outstanding: 54,577,626
  Share Type: Ordinary Closely Held Shares: 6,765,458
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.